BHAVESH PATEL: Open Payments
NPI 1417985730 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,550 in 76 payments from 19 companies in 2025. Trend: 2023 $1,860 · 2024 $1,583 · 2025 $1,550
Food & beverage: $1,441Education: $109
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $287 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $188 |
| Teva Pharmaceuticals USA, Inc. | 5 | $182 |
| Otsuka America Pharmaceutical, Inc. | 11 | $164 |
| Almatica Pharma LLC | 5 | $120 |
| ABBVIE INC. | 6 | $108 |
| Neurocrine BioSciences, Inc. | 4 | $97 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Corium, LLC | 2 | $48 |
Products named: FANAPT, CAPLYTA, REXULTI, LOREEV XR, VRAYLAR, INGREZZA, AUSTEDO XR, Auvelity.
Industry payments across GA — which companies pay providers there.
